Elite Pharmaceuticals Inc (ELTP): Clopidogrel is a P2Y12 inhibitor, used t...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Elite Pharmaceuticals Inc (ELTP)

Reply Private New

Keep Last Read

Next 10 Prev Next

PH4RM4C3UT1C4LS

Send PM Follow Ignore

Followers	16
Posts	329
Boards Moderated	0
Alias Born	01/21/2016

PH4RM4C3UT1C4LS

Re: Steges post# 224432

Monday, 08/29/2016 3:28:15 PM

Monday, August 29, 2016 3:28:15 PM

Clopidogrel is a P2Y12 inhibitor, used to stop ADP from binding to a platelet receptor within the aggregation-clotting cascade. AKA an anti platelet treatment.

The 4 ANDAs.... 2 are B-Blockers and 2 are stims.

In short, I like your DD, but no it is not clopidogrel-Plavix.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ELTP News

Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM

More ELTP News

InvestorsHub NewsWire

FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow